Variant NM_000492.4:c.3197G>T


Variant details:
Name NM_000492.4:c.3197G>T
Protein name NP_000483.3:p.(Arg1066Leu)
Genomic name (hg19) chr7:g.117251692G>T    UCSC    
#Exon/intron exon 20
Legacy Name R1066L
Class disease-causing
Subclass CF-causing
WT sequence AGCTTAAAAGGACTATGGACACTTC G TGCCTTCGGACGGCAGCCTTACTTT
Mutant sequence AGCTTAAAAGGACTATGGACACTTC T TGCCTTCGGACGGCAGCCTTACTTT

Other databases:

Not found		dbSNP
rs121909019



Pathogenicity predictors:

Functional studies:


Reference PMID Splicing mRNA level Maturation Localization Channel fonction (Cl-) Bicarbonate
Seibert et al, 1996 8662892 ✓ ✓
Cotten et al, 1996 8702904 ✓ ✓


« ✓ » indicates the type of analysis performed and not the results




No patient found in CFTR-NGS catalogue


2 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 2
CF 2




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 1701heterozygoteCF-causing- Undef
CF 3732heterozygoteCF-causing- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare